Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,247 of 4,734    |
|    =?UTF-8?B?4oqZ?= to All    |
|    ALZHEIMER'S DISEASE - METAL FATIGUE (1/2    |
|    22 Nov 14 19:44:29    |
      From: 23x11.5c@gmail.com              What Doctors Don't Tell You: ALZHEIMER'S DISEASE - METAL FATIGUE               What Doctors Don't Tell You © (Volume 5, Issue 12)                     In the search for a magic bullet, orthodox medicine ignores preliminary       evidence suggesting that some forms of dementia may be caused by metallic       poisoning.       In the US around four million men and women suffer from Alzheimer's disease       (AD), and in the UK over 600,000, mostly over the age of 65 years. As the       world elderly population increases, so too does the incidence of AD. The       disease is ultimately fatal in        every case, with an average seven years from onset to death.              Despite over 30 years of research, mainstream medicine has come up with       neither a cause nor a cure for AD. In doing so, the establishment is ignoring       startling new evidence that AD could be, to a large extent, an environmental       disease. Although AD is an        umbrella term, now used to characterize all sorts of dementias in the elderly,       recent, preliminary evidence suggests that classic Alzheimer's may have       something to do with poisoning from toxic metals.              Aluminium an established neurotoxin has long been linked to AD; high levels of       both metallic elements have been found in the brains of people with AD.              However, recent attention has focused on research published last year that       claims there is no connection whatsoever between aluminium and AD (Nature,       November 1994).              This study found no trace of aluminium in the brains of dead Alzheimer's       patients, and suggested that previous studies that had, did so as a result of       laboratory contamination, possibly through dyes used to stain the tissue for       analysis. This does not        explain why aluminium was not found in the brain tissue taken from control       groups, though.              It has also been suggested that the nuclear microscope the team used to       examine brain tissue may not have been as sensitive to aluminium as the       chemical method used in previous studies.              It is difficult to dismiss the many previous studies which have made a       connection between aluminium and AD, the latest also published only last year,       which concluded that their findings "are consistent with a role for aluminium       in the development of AD-       like pathology in patients subjected to prolonged aluminium exposure" (The       Lancet, April 23, 1994).              This lends itself to the argument that, rather than being a cause of AD,       aluminium may accumulate in the brain because of the disease processes. Dr       John Growdon stated that aluminium may act as a neurotoxin in AD, or might       just accumulate in dying nerve        cells (New England Journal of Medicine, March 18, 1993), and a 1993 study       concluded that aluminium and other metallic elements may gain increased access       to the brain through alterations in the brain and other organs (Experimental       Gerontology, July-Oct        1993).              An earlier study suggested that rather than being a cause of AD per se, high       levels of aluminium in the brain may cause an AD-type dementia (Ciba       Foundation Symposium, 1992; 169: 142-54). This is supported by high levels of       aluminium having been found in        the brains of people suffering from a brain disease known as dialysis dementia       (The Lancet, March 21, 1992). High levels of aluminium have also been found in       the brains of people with Down's syndrome, which has similar neurochemical       features to Alzheimer'       s disease. People with Down's also have a predisposition to AD (The Lancet,       March 31, 1990).              As well as drinking water, in which aluminium levels vary from area to area,       aluminium is found in foodstuffs, cosmetics, deodorants and pharmaceuticals,       particularly some antacids. Aluminium utensils and drink cans have also been       touted as a possible        danger.              One study found that aluminium concentration was far higher in several       commercially available brands of fresh and reconstituted orange juice, and       concluded that drinking most brands of so called fresh and pure orange juice       might result in far greater        exposure to aluminium than drinking a similar volume of tap water (The Lancet,       May 16, 1992).              Silicic acid and fluoride are said to protect against excess accumulation of       aluminium, although increased accumulation in lung, bone and brain does occur       with age (The Lancet, March 21, 1992).              But the most damning new research points the finger at mercury, a substance       rated among the most toxic known to man, particularly that present in amalgam       fillings.              A medical research team at the University of Kentucky in Lexington, Kentucky,       who have been investigating the possible link between mercury and AD, found       high levels of the element in the brain tissue of AD victims (Neurotoxicology,       1986; 7: 197-206;        Biol Trace Element Res, 1987; 13: 19-23), and WR Markesbery and his team found       that the highest trace element in the brains of 10 autopsied AD patients was       mercury (Brain Research, 1990; 533: 125-31).              As with aluminium, however, the Markesbery study noted that whether mercury       was a possible cause of AD, or simply a deposit on a degenerating brain,       remained to be determined. They concluded: "This and our previous studies       suggest that mercury toxicity        could play a role in neuronal degeneration in AD."              The link between mercury and AD was strengthened by Haley et al, who found       that mercury fed rats developed a diminished tubulin level similar to people       with AD. Tubulin is a protein needed for the healthy formation of nerve tissue       in the brain, and a        lack of tubulin will result in messages in the brain not connecting properly.       When fed aluminium, the rats displayed no change in tubulin levels (Federation       of American Societies for Experimental Biology, 75th Annual Meeting, 21-25       April 1991).              Markesbery and his team also found diminished levels of zinc and selenium in       the 10 AD-affected brains they examined. This is significant in that zinc and       selenium are known to have a protective role against heavy metal poisoning in       tissue.              It has also been suggested that low levels of zinc, coupled with high levels       of mercury, could make the brain more susceptible to aluminium deposits. Or       that mercury and aluminium both contribute to AD.              The Markesbery team noted that "the source of brain mercury in AD is not       known, although dental amalgams and environmental sources such as seafood are       potential sources". However, even the World Health Organization concedes that       the public's highest        daily exposure to mercury comes from dental amalgam fillings. (For a more       detailed analysis of the potential dangers associated with amalgam, see The       WDDTY Dental Handbook).                     [continued in next message]              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca